ose immunotherapeutics reports full year 2025 unaudited consolidated financial results and 2026 q1 cash position

TAX_FNCACT_FINANCIERSTRIALMEDICALWB_1331_HEALTH_TECHNOLOGIES

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.